文献速递心力衰竭与心肌病

早期主动脉内球囊反搏支持用于心力衰竭相关心源性休克:一项随机临床试验

Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock: A Randomized Clinical Trial.
PubMed 文献 · J Am Coll Cardiol · 2025-03-30

预设中期分析因无效而提前终止,两组主要终点无显著差异(81% vs 75%,HR 0.72,95%CI 0.31–1.68,P=0.45),并发症相当。

要点

  • 早期常规 IABP 未显著改善 HF-CS 患者 60 天生存或成功桥接至心脏替代治疗。
  • 试验因预设中期分析显示无效而提前终止,样本量小(IABP 组 53 例,对照组 48 例)。
  • 两组并发症相当,但结果需在更大规模研究中验证。

核心结论

  • 与标准治疗相比,早期 IABP 联合标准治疗未显著改善 HF-CS 患者 60 天生存或成功桥接至心脏替代治疗。

研究设计与样本

  • 多中心、前瞻性随机临床试验 Altshock-2,纳入 SCAI B、C 或 D 期 HF-CS 且适合心脏替代治疗的患者,随机分配至早期 IABP 联合标准治疗组(53 例)或标准治疗组(48 例)。

主要发现

  • 主要终点在 IABP 组 43 例(81%)达到,对照组 36 例(75%)达到(HR 0.72;95%CI 0.31–1.68;P=0.45)。
  • 60 天随访期间共 37 例(37%)接受心脏替代治疗。
  • 研究组 4 例(7.5%)升级治疗,对照组 2 例(4.2%)升级治疗。
  • 初始分配至标准治疗组的 6 例(13%)交叉至 IABP。
  • 两组并发症相当。

临床怎么用

  • 对于 HF-CS 且适合心脏替代治疗的患者,不推荐常规早期使用 IABP 以期改善 60 天生存或桥接成功率。

局限性

  • 存在交叉治疗(标准治疗组 6 例交叉至 IABP),可能稀释意向性治疗分析的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of intra-aortic balloon pump (IABP) on survival and successful bridging to heart replacement therapies (HRT) in patients with heart failure-cardiogenic shock (HF-CS) remains unclear. OBJECTIVES: The purpose of this study was to evaluate the effect of early IABP use vs standard care on 60-day survival or successful bridging to HRT. METHODS: In the multicenter, prospective Altshock-2 (Study on Early Intra-aortic Balloon Pump Placement in Acute Decompensated Heart Failure Complicated by Cardiogenic Shock), patients with Society for Cardiovascular Angiography and Interventions stage B, C, or D HF-CS and suitable for HRT were randomized to receive early IABP plus standard care (IABP group) or standard care (control group). The primary endpoint was survival or successful bridge to HRT at 60 days. Secondary endpoints included overall survival, maximum inotropic score, and maximum sequential organ failure assessment score. RESULTS: In total, 53 patients were randomized to IABP and 48 to standard care. Patients were Society for Cardiovascular Angiography and Interventions stage B (28%, n = 28), C (57%, n = 56), and D (15%, n = 16). At the prespecified interim analysis, the trial was stopped because of futility. The primary endpoint was reached in 43 patients (81%) in the IABP group and 36 patients (75%) in the control group (HR: 0.72; 95% CI: 0.31-1.68; P = 0.45). A total of 37 patients (37%) underwent HRT within the 60-day follow-up. Four patients were escalated in the study group (7.5%) vs 2 in the control group (4.2%). Additionally, 6 patients (13%) initially assigned to standard care crossed over to IABP. Complications were comparable between groups. CONCLUSIONS: Routine early IABP plus standard care, compared with standard care, did not significantly improve survival or successful bridging to HRT in patients with HF-CS. (Study on Early Intra-aortic Balloon Pump Placement in Acute Decompensated Heart Failure Complicated by Cardiogenic Shock [Altshock-2]; NCT04369573).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Morici, Sacco, Frea, et al. Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock: A Randomized Clinical Trial. J Am Coll Cardiol. 2025. PMID: 40162941. doi:10.1016/j.jacc.2025.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。